Ahmedabad-based Dishman Pharmaceuticals and Chemicals Ltd. registered a consolidated net profit of Rs 16.72 crore for the third quarter ended December 31, 2011, up by 904 per cent from Rs 1.67 crore for the corresponding period in previous fiscal 2010-11. As per the unaudited financial results announced by the company on Thursday, the consolidated turnover of Dishman increased by 14.54 per cent to Rs 265.46 crore in Q3 of FY'12 as against Rs 231.76 crore in the previous year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app